Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BYMedical sciences (Basel, Switzerland)

Infectious Complications in Adults Receiving Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis of Nosocomial and Bloodstream Infection, Prevalence, Risk Factors, and Clinical Outcomes.

1 more authors
  1. 1Department of Infectious Diseases, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.
  2. 2Department of Medical Intensive Care, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.
  3. 3Medical College, Qatar University, Doha P.O. Box 2713, Qatar.

Abstract

Background/objectives

Reported infection rates during extracorporeal membrane oxygenation (ECMO) vary widely, partly because case definitions are applied inconsistently. We synthesized the prevalence and prognostic association of nosocomial and bloodstream infection (BSI) acquired during adult ECMO.Methods

PubMed/MEDLINE, Embase, Scopus and CENTRAL were searched through December 2025 for observational studies of at least 10 adults on ECMO with an explicit infection definition. We classified case definitions by the criteria actually applied. We pooled crude mortality odds ratios (ORs) and patient-level BSI prevalence in studies applying laboratory-confirmed criteria, assessed risk of bias with ROBINS-I and the JBI checklist, and rated certainty with GRADE.Results

Forty-seven reports (46 cohorts; 11,573 patients) were included. Pooled BSI prevalence was 25.8% (95% CI 17.3-36.5%; 7 studies, 1193 patients), 18.2% in pre-pandemic and 39.2% in COVID-19 cohorts (post hoc). Infection was associated with higher crude odds of death (OR 1.65, 1.33-2.04; prediction interval 0.95-2.85; 24 studies), but analyses modeling infection as time-varying were inconsistent, including no association in a multistate model (adjusted hazard ratio 1.00, 0.79-1.26), and small-study effects were suggested. Certainty was very low for both outcomes.Conclusions

Roughly one in four adults on ECMO developed laboratory-confirmed BSI, more often in COVID-19 cohorts. Whether infection acquired on ECMO increases mortality remains uncertain.

Related

  1. Infectious complications following heart transplantation in the era of high-priority allocation and extracorporeal membrane oxygenation
    Stéphanie Pons, Romain Sonneville, Lila Bouadma +11
    Annals of Intensive CarePeer-reviewedCC BYFull text61 citedSurgery & anaesthesiaHAL
  2. Clinical Outcomes and Complications of Extracorporeal Membrane Oxygenation (ECMO) in Adult Patients With COVID-19 in Central and Eastern Europe: A Systematic Review and Meta-Analysis
    Konstanty Szułdrzyński, Miłosz Jankowski, Zsolt Molnar +8
    Medical Science Monitor: International Medical Journal of Experimental and Clinical ResearchPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  3. Risk Factors for Metastatic Infectious Complications in Patients with Catheter-Related Bloodstream Infection
    Audrey Lanyan, Nicolas Fourré, Virgile Zimmermann +3
    Antibiotics (Basel, Switzerland)Peer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCDOAJ
  4. Mixing point thrombus during veno-arterial extracorporeal membrane oxygenation support
    European heart journal. Case reportsPeer-reviewedCC BY-NCFull textCardiovascular medicineEurope PMC
  5. Early recognition of life-threatening otolaryngologic complications in pediatric epstein-barr virus infectious mononucleosis: a systematic review and meta-analysis.
    Sara Torretta, Giulia De Lucia, Silvia Cavalera +2
    Frontiers in pediatricsPeer-reviewedCC BYFull textOncologyEurope PMC
BibTeX
@article{alzibdeh2026infectious,
  title = {{Infectious Complications in Adults Receiving Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis of Nosocomial and Bloodstream Infection, Prevalence, Risk Factors, and Clinical Outcomes.}},
  author = {Aseel Alzibdeh and Ans Alamami and Sabeen Zara and Maha Aljabri and Rabee Tawel and Samar Hashim and Abdurrahmaan Elbuzidi and Hamad Abdelhadi and Ahmed Labib Shehatta and Nadir Kharma and Abdulsalam Saif Ibrahim and Ibrahim Fawzy Hassan and Muna Almaslamani},
  journal = {Medical sciences (Basel, Switzerland)},
  year = {2026},
  month = oct,
  doi = {10.3390/medsci14060653},
  url = {https://europepmc.org/article/MED/42930572},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Infectious Complications in Adults Receiving Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis of Nosocomial and Bloodstream Infection, Prevalence, Risk Factors, and Clinical Outcomes.
AU  - Aseel Alzibdeh
AU  - Ans Alamami
AU  - Sabeen Zara
AU  - Maha Aljabri
AU  - Rabee Tawel
AU  - Samar Hashim
AU  - Abdurrahmaan Elbuzidi
AU  - Hamad Abdelhadi
AU  - Ahmed Labib Shehatta
AU  - Nadir Kharma
AU  - Abdulsalam Saif Ibrahim
AU  - Ibrahim Fawzy Hassan
AU  - Muna Almaslamani
PY  - 2026
DA  - 2026/10/09
JO  - Medical sciences (Basel, Switzerland)
DO  - 10.3390/medsci14060653
UR  - https://europepmc.org/article/MED/42930572
AB  - Background/objectives  Reported infection rates during extracorporeal membrane oxygenation (ECMO) vary widely, partly because case definitions are applied inconsistently. We synthesized the prevalence and prognostic association of nosocomial and bloodstream infection (BSI) acquired during adult ECMO.Methods  PubMed/MEDLINE, Embase, Scopus and CENTRAL were searched through December 2025 for observational studies of at least 10 adults on ECMO with an explicit infection definition. We classified case definitions by the criteria actually applied. We pooled crude mortality odds ratios (ORs) and patient-level BSI prevalence in studies applying laboratory-confirmed criteria, assessed risk of bias with ROBINS-I and the JBI checklist, and rated certainty with GRADE.Results  Forty-seven reports (46 cohorts; 11,573 patients) were included. Pooled BSI prevalence was 25.8% (95% CI 17.3-36.5%; 7 studies, 1193 patients), 18.2% in pre-pandemic and 39.2% in COVID-19 cohorts (post hoc). Infection was associated with higher crude odds of death (OR 1.65, 1.33-2.04; prediction interval 0.95-2.85; 24 studies), but analyses modeling infection as time-varying were inconsistent, including no association in a multistate model (adjusted hazard ratio 1.00, 0.79-1.26), and small-study effects were suggested. Certainty was very low for both outcomes.Conclusions  Roughly one in four adults on ECMO developed laboratory-confirmed BSI, more often in COVID-19 cohorts. Whether infection acquired on ECMO increases mortality remains uncertain.
SN  - 2076-3271
ER  -